Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • A Closer Look at Type 1 Diabetes Causal Variants

    Sep 7, 2021, 07:43 AM by User Not Found
    Bio-IT World | Researchers from the University of Virginia and the University of Oxford have been tracing the genes responsible for type 1 diabetes for years. The team just published the largest look yet: exploring the genomes of more than 61,000 individuals of diverse ancestry to better understand the genetic underpinnings of this complex disease.
    Full story
  • Follow the Money: Next Gen Oligonucleotides, ML Insights Platform

    Sep 3, 2021, 13:41 PM by User Not Found
    Bio-IT World | HealthTech SPAC funding, wearable fitness program for metabolic health disorders, multiple academic grants for dementia research, using AI to watch cells over time, and more.
    Full story
  • New Results from BabySeq, Pharmacogenomic Updates, New Products

    Sep 1, 2021, 01:00 AM by User Not Found
    Bio-IT World | Harvard-Israel and Sema4-Avera launch precision medicine partnerships, Rice announces new Genetic Design and Engineering Center, Foundation Medicine partners with Epic, and Amgen and USC provide cryo-TEMs. Plus new products from BioIVT, BD.
    Full story
  • Artificial Intelligence Calculates Anti-Aging Properties Of Compounds

    Aug 31, 2021, 02:30 AM by User Not Found
    Bio-IT World | Artificial intelligence (AI) has been paired with one of the simplest of organisms—the nematode Caenorhabditis elegans—to enlighten the scientific community about the physical and chemical properties of drug compounds with anti-aging effects.
    Full story
  • Superbugs and the Flawed Antibiotic Development Model, Alert to a Growing Global Health Risk

    Aug 27, 2021, 01:00 AM by User Not Found
    Bio-IT World | After over a year of the coronavirus pandemic, it’s hard to picture another global health crisis emerging, but data indicates bacterial infections could cause the next pandemic, as several known “superbugs” have adapted to resist all available antibiotics. The effects could be highly detrimental if today’s antibiotic development model doesn’t evolve and take priority. Antibiotics typically take an average of 10-15 years to develop and at high costs, roughly 1-2 billion dollars. This is due in part to the long, risky drug development process that has become the standard.
    Full story
  • Discovery on Target: A Deeper Look at 3D Cellular Models

    Aug 26, 2021, 01:00 AM by User Not Found
    Bio-IT World | “This field is developing so rapidly. If it has been six months…, you're behind.” That’s how Christopher Austin describes the 3D cellular models research landscape. As the past director for NCATS, the National Center for Advancing Translational Sciences, Chris knows the pace of this research area well. He recently left NCATS to serve as one of Flagship Pioneering’s CEO-Partners.
    Full story
  • Biochip Platform Could Enable Personalized Immunotherapy

    Aug 25, 2021, 01:00 AM by User Not Found
    Bio-IT World | Rensselaer Polytechnic Institute and South Korean biotech Medical & Bio Decision Company Ltd. (MBD) are working on turning a biochip into a personalized immunotherapy platform for rapidly screening a wide range of treatment cocktails for individual cancer patients. The platform would be ideally suited for very small tumor biopsy samples.
    Full story
  • NIH Awards $53M for HIV Cure Research for Adults, Children

    Aug 23, 2021, 10:49 AM by User Not Found
    Bio-IT World | The National Institutes of Health has awarded approximately $53 million in annual funding over the next five years to 10 research organizations in a continued effort to find a cure for HIV.
    Full story
  • Cisco fixes vulnerability that allowed criminals to remotely execute arbitrary code and control a firewall

    Aug 20, 2021, 11:51 AM by
    Positive Technologies researchers discovered a vulnerability in Cisco Firepower Device Manager On-Box – a product designed to locally configure Cisco Firepower firewalls. Now patched, the flaw could allow attackers to gain full control over the device and its capabilities. That could include handing over to criminals the ability to filter traffic. Attackers could also shut down a firewall, or even access other internal resources within an enterprise, if they’re located on the same subnet.
    Full story
  • Sensyne grows medical research dataset to 60 million patients

    Aug 20, 2021, 11:51 AM by
    Deep longitudinal, disease agnostic structured global dataset, covering over 4,000 indications will industrialize Sensyne’s life sciences activities
    Full story
  • Biofourmis Earns FDA’s First-Ever Breakthrough Device Designation for a Novel Digital Therapeutic for Heart Failure

    Aug 20, 2021, 11:51 AM by
    Biofourmis completed a proof of concept study for its heart failure digital therapeutic BiovitalsHF that met its endpoint of number of patients at 50% of optimal therapy. As a result, FDA has granted the DTx the first-ever Breakthrough Designation for a heart failure digital therapy.
    Full story
  • Stelis Biopharma appoints Mark W. Womack as the new CEO

    Aug 20, 2021, 11:43 AM by
    Full story
  • Amerigo Scientific Launches New AcrB Transporter for Therapeutic Indications

    Aug 20, 2021, 11:43 AM by
    Amerigo Scientific recently launches AcrB transporter that aids in the identification, development, refinement, and validation of new molecules and therapeutic antibodies.
    Full story
  • BIO-ISAC founded to protect and build resilience from increasing attacks on public and private bioeconomy infrastructure

    Aug 20, 2021, 11:43 AM by
    Full story
  • Advanced Instruments to Acquire Solentim, a Trusted Global Leader in Cell Imaging for Cell Line Development and Clone Characterization

    Aug 20, 2021, 11:43 AM by
    Advanced Instruments, a leading manufacturer of analytical instruments and services for bioprocessing, today announced the execution of a definitive agreement to acquire Solentim, a trusted global leader of solutions for the isolation and characterization of high value single cell clones in cell line development (CLD) applications.
    Full story
  • DNAnexus Platform Exceeds Online Security Standards in President Biden’s Executive Order Aimed at Protecting American Infrastructure from Cyberattacks

    Aug 20, 2021, 11:41 AM by
    DNAnexus platform exceeds online security policy objectives outlined in President Biden’s executive order protecting American infrastructure from cyberattacks
    Full story
  • FDB Launches Clinical Decision Support Analytics Solution

    Aug 20, 2021, 11:41 AM by
    FDB Launches Clinical Decision Support Analytics Solution
    Full story
  • Lightbeam Health Solutions Announces Partnership with Genetic Testing Company, Ambry Genetics

    Aug 20, 2021, 11:41 AM by
    Lightbeam Health Solutions Announces Partnership with Genetic Testing Company, Ambry Genetics
    Full story
  • Dotmatics to deliver the foundation for Croda’s R&D digital program: artificial intelligence and data mining

    Aug 20, 2021, 11:41 AM by
    For further information on Dotmatics, please visit www.dotmatics.com
    Full story
  • Heraeus completes multi-million Euro cancer therapy API capacity expansion

    Aug 20, 2021, 11:41 AM by
    Heraeus Pharmaceutical Ingredients’ additional production line for Platinum-based highly potent active pharmaceutical ingredients (Pt hAPIs) is now fully operational at the company’s headquarters in Hanau, Germany.
    Full story
  • «
  • 161
  • 162 (current)
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy